 |
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Thursday, May 23, 2013
|
|
|
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Thursday, May 23, 2013
|
| Home | HealthTopics | Health Centers | Reference Library | Research |
 Join us on Facebook
|
Share on Facebook | Tweet |
|
Colon Cancer |
Colon cancer patient using vectibix09/06/2007 |
What is their survival rate after eleven months of chemo and no other options but vextibix.
It is difficult to answer without knowing more details. But in patients who failed multiple therapies and got vectibix only, average survival is less than 6 months.
|
Malek Safa, MD Assistant Professor of Medicine College of Medicine University of Cincinnati |
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|